TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

CUSIP: 88338N206

Q4 2025 13F Holders as of 31 Dec 2025

Security identity
Security type / class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
11,676,558
Holder snapshot
Total 13F shares
3,384,889
Share change
+81,101
Total reported value
$5,517,397
Reported price per share
$1.63
Number of holders
41
Value change
+$146,413
Number of buys
11
Number of sells
13

Security key

88338N206

Report period

Q4 2025

Institutions

41

Top holders

10

TXMD full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 TherapeuticsMD, Inc. SEC filings TherapeuticsMD, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Clearline Capital LP
13D/G signal
Clearline Capital LP
Evidence rows
15
Latest as of
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 5.5% 13D/G row: Clearline Capital LP Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Clearline Capital LP
13D/G 13F
Company
13D/G 13F
5.5%
$705,096
635,222 shares
 $0 31 Dec 2024
Rubric Capital Management LP
3/4/5 13F
Director, Other*, 10%+ Owner · Company
3/4/5 13F
10%
from 13F
$6,718,950
2,946,908 shares
 — 15 Nov 2023
VANGUARD GROUP INC
13F
Company
13F
3.2%
$399,437
376,828 shares
 — 30 Sep 2025
Tejara Capital Ltd
13F
Company
13F
2.9%
$370,018
344,203 shares
 — 30 Sep 2025
ADAR1 Capital Management, LLC
13F
Company
13F
1.8%
$224,901
209,210 shares
 — 30 Sep 2025
MORGAN STANLEY
13F
Company
13F
1.1%
$140,365
130,572 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
41
Shares
3,384,889
Rows available
41
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
43
Q4 2025 holders
41
Holder diff
-2
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .